Qure.ai, a Mumbai, India-based healthcare AI innovator, raised $65M in Series D funding.
The round was led by Lightspeed and 360 ONE Asset, joined by Merck Global Health Innovation Fund and Kae Capital. Existing investors Novo Holdings, Health Quad, and TeamFund also participated.
The company intends to use the funds to expedite expansion into the US market and other geographies, increase investment into foundational AI models and enable complementary med-tech company acquisitions.
Founded in 2016 and led by CEO Prashant Warier, Qure.ai aims to make healthcare more accessible and equitable globally. Its solutions are deployed in over 90 countries across 3000+ sites, empowering the identification and management of critical diseases.
The company has 18 FDA-cleared indications, and its products are Class IIb certified per EU MDR* regulations. Qure.ai has regional offices in New York, London, and Dubai.
*Regulatory clearances vary by region
FinSMEs
25/09/2024